Fate of embryonal carcinoma cells injected into postimplantation mouse embryos

Simonetta Astigiano, Patrizia Damonte, Sara Fossati, Luca Boni, Ottavia Barbieri

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Embryonal carcinoma (EC) cells, stem cells of teratocarcinoma, represent an excellent model to study the developmental mechanisms that, inappropriately reactivated, can drive tumorigenesis. EC cells are very aggressive, and grow rapidly when injected into adult syngeneic mice. However, when injected into blastocysts, they revert to normality, giving rise to chimeric animals. In order to study the ability of postimplantation embryonic environment to "normalize" tumorigenic cells, and to study their homing, we transplanted F9, Nulli-SCC1, and P19 EC cells into 8 to 15-day allogenic CD1 mouse embryos, into allogenic CD1 newborns, and into syngeneic adult mice, and evaluated tumor formation, spreading, and homing. We found that, although at all embryonic stages successful transplantation occurred, the chances of developing tumors after birth increased with the time of injection of EC cells into the embryo. In addition, using enhanced green fluorescent protein-expressing F9 cells, we demonstrated that the cells not giving rise to tumors remained latent and could be tracked down in tissues during adulthood. Our data indicate that the embryonic environment retains a certain ability to "normalize" tumor cells also during post-implantation development. This could occur through yet unknown epigenetic signals triggering EC cells' differentiation.

Original languageEnglish
Pages (from-to)484-490
Number of pages7
JournalDifferentiation
Volume73
Issue number9-10
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Embryonal Carcinoma Stem Cells
Embryonic Structures
Neoplasms
Blastocyst
Epigenomics
Cell Differentiation
Carcinogenesis
Transplantation
Parturition
Injections

Keywords

  • Embryo microenvironment
  • Embryonal carcinoma cells
  • Tumor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Developmental Biology
  • Cell Biology

Cite this

Astigiano, S., Damonte, P., Fossati, S., Boni, L., & Barbieri, O. (2005). Fate of embryonal carcinoma cells injected into postimplantation mouse embryos. Differentiation, 73(9-10), 484-490. https://doi.org/10.1111/j.1432-0436.2005.00043.x

Fate of embryonal carcinoma cells injected into postimplantation mouse embryos. / Astigiano, Simonetta; Damonte, Patrizia; Fossati, Sara; Boni, Luca; Barbieri, Ottavia.

In: Differentiation, Vol. 73, No. 9-10, 12.2005, p. 484-490.

Research output: Contribution to journalArticle

Astigiano, S, Damonte, P, Fossati, S, Boni, L & Barbieri, O 2005, 'Fate of embryonal carcinoma cells injected into postimplantation mouse embryos', Differentiation, vol. 73, no. 9-10, pp. 484-490. https://doi.org/10.1111/j.1432-0436.2005.00043.x
Astigiano, Simonetta ; Damonte, Patrizia ; Fossati, Sara ; Boni, Luca ; Barbieri, Ottavia. / Fate of embryonal carcinoma cells injected into postimplantation mouse embryos. In: Differentiation. 2005 ; Vol. 73, No. 9-10. pp. 484-490.
@article{e7bc5ab39fb441989d57e7142bf91305,
title = "Fate of embryonal carcinoma cells injected into postimplantation mouse embryos",
abstract = "Embryonal carcinoma (EC) cells, stem cells of teratocarcinoma, represent an excellent model to study the developmental mechanisms that, inappropriately reactivated, can drive tumorigenesis. EC cells are very aggressive, and grow rapidly when injected into adult syngeneic mice. However, when injected into blastocysts, they revert to normality, giving rise to chimeric animals. In order to study the ability of postimplantation embryonic environment to {"}normalize{"} tumorigenic cells, and to study their homing, we transplanted F9, Nulli-SCC1, and P19 EC cells into 8 to 15-day allogenic CD1 mouse embryos, into allogenic CD1 newborns, and into syngeneic adult mice, and evaluated tumor formation, spreading, and homing. We found that, although at all embryonic stages successful transplantation occurred, the chances of developing tumors after birth increased with the time of injection of EC cells into the embryo. In addition, using enhanced green fluorescent protein-expressing F9 cells, we demonstrated that the cells not giving rise to tumors remained latent and could be tracked down in tissues during adulthood. Our data indicate that the embryonic environment retains a certain ability to {"}normalize{"} tumor cells also during post-implantation development. This could occur through yet unknown epigenetic signals triggering EC cells' differentiation.",
keywords = "Embryo microenvironment, Embryonal carcinoma cells, Tumor",
author = "Simonetta Astigiano and Patrizia Damonte and Sara Fossati and Luca Boni and Ottavia Barbieri",
year = "2005",
month = "12",
doi = "10.1111/j.1432-0436.2005.00043.x",
language = "English",
volume = "73",
pages = "484--490",
journal = "Differentiation",
issn = "0301-4681",
publisher = "Elsevier BV",
number = "9-10",

}

TY - JOUR

T1 - Fate of embryonal carcinoma cells injected into postimplantation mouse embryos

AU - Astigiano, Simonetta

AU - Damonte, Patrizia

AU - Fossati, Sara

AU - Boni, Luca

AU - Barbieri, Ottavia

PY - 2005/12

Y1 - 2005/12

N2 - Embryonal carcinoma (EC) cells, stem cells of teratocarcinoma, represent an excellent model to study the developmental mechanisms that, inappropriately reactivated, can drive tumorigenesis. EC cells are very aggressive, and grow rapidly when injected into adult syngeneic mice. However, when injected into blastocysts, they revert to normality, giving rise to chimeric animals. In order to study the ability of postimplantation embryonic environment to "normalize" tumorigenic cells, and to study their homing, we transplanted F9, Nulli-SCC1, and P19 EC cells into 8 to 15-day allogenic CD1 mouse embryos, into allogenic CD1 newborns, and into syngeneic adult mice, and evaluated tumor formation, spreading, and homing. We found that, although at all embryonic stages successful transplantation occurred, the chances of developing tumors after birth increased with the time of injection of EC cells into the embryo. In addition, using enhanced green fluorescent protein-expressing F9 cells, we demonstrated that the cells not giving rise to tumors remained latent and could be tracked down in tissues during adulthood. Our data indicate that the embryonic environment retains a certain ability to "normalize" tumor cells also during post-implantation development. This could occur through yet unknown epigenetic signals triggering EC cells' differentiation.

AB - Embryonal carcinoma (EC) cells, stem cells of teratocarcinoma, represent an excellent model to study the developmental mechanisms that, inappropriately reactivated, can drive tumorigenesis. EC cells are very aggressive, and grow rapidly when injected into adult syngeneic mice. However, when injected into blastocysts, they revert to normality, giving rise to chimeric animals. In order to study the ability of postimplantation embryonic environment to "normalize" tumorigenic cells, and to study their homing, we transplanted F9, Nulli-SCC1, and P19 EC cells into 8 to 15-day allogenic CD1 mouse embryos, into allogenic CD1 newborns, and into syngeneic adult mice, and evaluated tumor formation, spreading, and homing. We found that, although at all embryonic stages successful transplantation occurred, the chances of developing tumors after birth increased with the time of injection of EC cells into the embryo. In addition, using enhanced green fluorescent protein-expressing F9 cells, we demonstrated that the cells not giving rise to tumors remained latent and could be tracked down in tissues during adulthood. Our data indicate that the embryonic environment retains a certain ability to "normalize" tumor cells also during post-implantation development. This could occur through yet unknown epigenetic signals triggering EC cells' differentiation.

KW - Embryo microenvironment

KW - Embryonal carcinoma cells

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=33644877602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644877602&partnerID=8YFLogxK

U2 - 10.1111/j.1432-0436.2005.00043.x

DO - 10.1111/j.1432-0436.2005.00043.x

M3 - Article

VL - 73

SP - 484

EP - 490

JO - Differentiation

JF - Differentiation

SN - 0301-4681

IS - 9-10

ER -